ANDREA BRANCH: Open Payments
NPI 1134638034 · COLUMBUS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 33 payments from 8 companies in 2025. Trend: 2023 $224 · 2024 $462 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $236 |
| AstraZeneca Pharmaceuticals LP | 6 | $138 |
| Amgen Inc. | 5 | $76 |
| Novo Nordisk Inc | 4 | $69 |
| Dexcom, Inc. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Shionogi Inc | 1 | $14 |
Products named: MOUNJARO, FARXIGA, Dexcom G6 Transmitter, Ozempic, OTEZLA, EVENITY, Kerendia, ZEPBOUND.
Industry payments across MS — which companies pay providers there.
